Clinical investigation in non-liver cirrhosis portosystemic shunt encephalopathy—four case series—

We reported here four cases presenting with disturbance of consciousness over long periods of time and hyperammonemia. Two patients were on maintenance hemodialysis. Contrast-enhanced computed tomography (CT) of abdomen and balloon-occluded retrograde contrast venography revealed existence of a non-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fumika Azuma, Kazuya Nokura, Tetsuharu Kako, Yoshihiko Horimoto, Eiichi Katada, Naohide Kondo, Yasuhiro Ito
Formato: article
Lenguaje:EN
Publicado: Fujita Medical Society 2021
Materias:
Acceso en línea:https://doaj.org/article/39119421d4a74ae18d696b34ce541001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:39119421d4a74ae18d696b34ce541001
record_format dspace
spelling oai:doaj.org-article:39119421d4a74ae18d696b34ce5410012021-11-10T04:40:26ZClinical investigation in non-liver cirrhosis portosystemic shunt encephalopathy—four case series—10.20407/fmj.2020-0082189-72472189-7255https://doaj.org/article/39119421d4a74ae18d696b34ce5410012021-11-01T00:00:00Zhttps://www.jstage.jst.go.jp/article/fmj/7/4/7_2020-008/_pdf/-char/enhttps://doaj.org/toc/2189-7247https://doaj.org/toc/2189-7255We reported here four cases presenting with disturbance of consciousness over long periods of time and hyperammonemia. Two patients were on maintenance hemodialysis. Contrast-enhanced computed tomography (CT) of abdomen and balloon-occluded retrograde contrast venography revealed existence of a non-cirrhotic portosystemic shunt. Conservative treatment such as intravenous branched-chain amino acid administration and oral lactulose administration had only a modest effect in all patients. Improvements in symptoms were observed following the occlusion of the shunt path in three patients. Measurements of ammonia values would be the most important test for screening, but changes in Fischer’s ratio or indocyanine green (ICG) test values were also correlated with clinical symptoms. Neurologists should keep in mind the possibility of non-cirrhotic portosystemic shunts when they encounter patients with disturbance of consciousness. They should also remember that occlusion of the shunt pathway is an effective treatment.Fumika AzumaKazuya NokuraTetsuharu KakoYoshihiko HorimotoEiichi KatadaNaohide KondoYasuhiro ItoFujita Medical Societyarticleportosystemic shuntencephalopathyhyperammonemiainterventional radiologyMedicine (General)R5-920ENFujita Medical Journal, Vol 7, Iss 4, Pp 139-142 (2021)
institution DOAJ
collection DOAJ
language EN
topic portosystemic shunt
encephalopathy
hyperammonemia
interventional radiology
Medicine (General)
R5-920
spellingShingle portosystemic shunt
encephalopathy
hyperammonemia
interventional radiology
Medicine (General)
R5-920
Fumika Azuma
Kazuya Nokura
Tetsuharu Kako
Yoshihiko Horimoto
Eiichi Katada
Naohide Kondo
Yasuhiro Ito
Clinical investigation in non-liver cirrhosis portosystemic shunt encephalopathy—four case series—
description We reported here four cases presenting with disturbance of consciousness over long periods of time and hyperammonemia. Two patients were on maintenance hemodialysis. Contrast-enhanced computed tomography (CT) of abdomen and balloon-occluded retrograde contrast venography revealed existence of a non-cirrhotic portosystemic shunt. Conservative treatment such as intravenous branched-chain amino acid administration and oral lactulose administration had only a modest effect in all patients. Improvements in symptoms were observed following the occlusion of the shunt path in three patients. Measurements of ammonia values would be the most important test for screening, but changes in Fischer’s ratio or indocyanine green (ICG) test values were also correlated with clinical symptoms. Neurologists should keep in mind the possibility of non-cirrhotic portosystemic shunts when they encounter patients with disturbance of consciousness. They should also remember that occlusion of the shunt pathway is an effective treatment.
format article
author Fumika Azuma
Kazuya Nokura
Tetsuharu Kako
Yoshihiko Horimoto
Eiichi Katada
Naohide Kondo
Yasuhiro Ito
author_facet Fumika Azuma
Kazuya Nokura
Tetsuharu Kako
Yoshihiko Horimoto
Eiichi Katada
Naohide Kondo
Yasuhiro Ito
author_sort Fumika Azuma
title Clinical investigation in non-liver cirrhosis portosystemic shunt encephalopathy—four case series—
title_short Clinical investigation in non-liver cirrhosis portosystemic shunt encephalopathy—four case series—
title_full Clinical investigation in non-liver cirrhosis portosystemic shunt encephalopathy—four case series—
title_fullStr Clinical investigation in non-liver cirrhosis portosystemic shunt encephalopathy—four case series—
title_full_unstemmed Clinical investigation in non-liver cirrhosis portosystemic shunt encephalopathy—four case series—
title_sort clinical investigation in non-liver cirrhosis portosystemic shunt encephalopathy—four case series—
publisher Fujita Medical Society
publishDate 2021
url https://doaj.org/article/39119421d4a74ae18d696b34ce541001
work_keys_str_mv AT fumikaazuma clinicalinvestigationinnonlivercirrhosisportosystemicshuntencephalopathyfourcaseseries
AT kazuyanokura clinicalinvestigationinnonlivercirrhosisportosystemicshuntencephalopathyfourcaseseries
AT tetsuharukako clinicalinvestigationinnonlivercirrhosisportosystemicshuntencephalopathyfourcaseseries
AT yoshihikohorimoto clinicalinvestigationinnonlivercirrhosisportosystemicshuntencephalopathyfourcaseseries
AT eiichikatada clinicalinvestigationinnonlivercirrhosisportosystemicshuntencephalopathyfourcaseseries
AT naohidekondo clinicalinvestigationinnonlivercirrhosisportosystemicshuntencephalopathyfourcaseseries
AT yasuhiroito clinicalinvestigationinnonlivercirrhosisportosystemicshuntencephalopathyfourcaseseries
_version_ 1718440543955976192